Erlinge, David <br/><br/>
Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial).  [electronic resource] 

 -  American heart journal  May 2016 
 - 36-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1016/j.ahj.2016.02.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravenous<br/>Aged<br/>Anticoagulants--administration & dosage<br/>Combined Modality Therapy<br/>Dose-Response Relationship, Drug<br/>Drug-Related Side Effects and Adverse Reactions--etiology<br/>Electrocardiography--methods<br/>Female<br/>Heparin--administration & dosage<br/>Hirudins--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Non-ST Elevated Myocardial Infarction--diagnosis<br/>Outcome and Process Assessment, Health Care<br/>Peptide Fragments--administration & dosage<br/>Percutaneous Coronary Intervention--methods<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Recombinant Proteins--administration & dosage<br/>Registries<br/>ST Elevation Myocardial Infarction--diagnosis<br/>Treatment Outcome